Genomictree will hold an investor relations meeting for domestic institutional investors on July 6, 2026, at institutional investor meeting rooms in Yeouido, Seoul.
The IR event aims to enhance investor understanding of the company and will be conducted as face-to-face meetings featuring company overview presentations and Q&A sessions.
The event is sponsored by Mirae Asset Securities, and IR materials will be posted on the Korea Exchange KIND system IR archive.
[AI Summary]This investor relations event is a routine communication activity with no capital raising or structural changes, thus no direct impact on shareholder value. It is expected to contribute to building long-term trust with institutional investors.